MENS
Jyong Biotech Ltd. Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$129.63M
P/E Ratio
—
EPS
$-0.06
Beta
—
52W High
$67.00
52W Low
$1.43
50-Day MA
$2.21
200-Day MA
$19.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. (ticker: MENS) is a pioneering biotechnology firm focused on developing advanced therapeutic solutions for cancer and autoimmune diseases. The company leverages its expertise in genomics and molecular biology to cultivate a diverse pipeline of innovative treatments, supported by a compelling intellectual property portfolio. Through strategic collaborations within the biopharmaceutical sector, Jyong Biotech is well-positioned to capitalize on emerging market opportunities while prioritizing scientific rigor and patient-centric approaches, establishing itself as a key player in the evolution of healthcare innovation.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-2.51M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -12.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.34 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $74.23M |
| Float | $26.94M |
| % Insiders | 62.20% |
| % Institutions | 0.71% |
Historical Volatility
HV 10-Day
68.52%
HV 20-Day
76.09%
HV 30-Day
68.21%
HV 60-Day
81.29%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026